Unknown

Dataset Information

0

Complement factor I and age-related macular degeneration.


ABSTRACT: PURPOSE: The complement system has been implicated in the pathogenesis of age-related macular degeneration (AMD). Complement factor I (CFI) is a serum protease that inhibits all complement pathways. A previous multicenter study identified a single missense CFI mutation (p.Gly119Arg) in 20/3,567 (0.56%) of AMD cases versus 1/3,937 (0.025%) of controls, thus suggesting that this mutation confers a high risk of AMD. A second CFI mutation, p.Gly188Ala, was identified in one patient with AMD. METHODS: We screened 521 unrelated AMD cases and 627 controls for the p.Gly119Arg and p.Gly188Ala variants. All participants were Caucasian and >55 years, and recruited through Southampton Eye Unit or research clinics in Guernsey. All participants underwent dilated fundal examination by an experienced retinal specialist. SNP assays were performed using KASP™ biochemistry. RESULTS: The p.Gly119Arg mutation was identified in 7/521 AMD cases compared to 1/627 age-matched controls (odds ratio [OR] = 8.47, confidence interval [CI] = 1.04-69.00, p = 0.027). There was a varied phenotype among the seven cases with the mutation, which was present in 4/254 (1.6%) cases with active or end-stage wet AMD and 3/267 dry AMD cases (1.1%). The p.Gly188Ala substitution was identified in 1/521 cases and 1/627 controls. CONCLUSIONS: Our results identified a much higher frequency of heterozygosity for p.Gly119Arg in both cases and controls than in previous studies. Of note is that our sub-cohort from Guernsey had a particularly high frequency of p.Gly119Arg heterozygosity in affected individuals (4%) compared to our sub-cohort from the mainland (0.71%). Although these data support the conclusions of van de Ven et al. that the p.Gly119Arg substitution confers a high risk of AMD, our data suggest that this missense mutation is not as rare or as highly penetrant as previously reported. There was no difference in frequency for a second CFI variant, p.Gly188Ala, between the cases and the controls.

SUBMITTER: Alexander P 

PROVIDER: S-EPMC4165324 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Complement factor I and age-related macular degeneration.

Alexander Philip P   Gibson Jane J   Cree Angela J AJ   Ennis Sarah S   Lotery Andrew J AJ  

Molecular vision 20140913


<h4>Purpose</h4>The complement system has been implicated in the pathogenesis of age-related macular degeneration (AMD). Complement factor I (CFI) is a serum protease that inhibits all complement pathways. A previous multicenter study identified a single missense CFI mutation (p.Gly119Arg) in 20/3,567 (0.56%) of AMD cases versus 1/3,937 (0.025%) of controls, thus suggesting that this mutation confers a high risk of AMD. A second CFI mutation, p.Gly188Ala, was identified in one patient with AMD.<  ...[more]

Similar Datasets

| S-EPMC3230905 | biostudies-literature
| S-EPMC1512523 | biostudies-literature
| S-EPMC2118454 | biostudies-literature
| S-EPMC3084221 | biostudies-literature
| S-EPMC6885067 | biostudies-literature
| S-EPMC2746818 | biostudies-literature
| S-EPMC3696004 | biostudies-literature
| S-EPMC4466717 | biostudies-literature
| S-EPMC4709545 | biostudies-literature
| S-EPMC2440421 | biostudies-literature